Cargando…
Cardiovascular rehabilitation with a WCD
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Private company. Main funding source(s): ZOLL BACKGROUND: The wearable cardioverter-defibrillator (WCD) is a temporary treatment option for patients at high risk for sudden cardiac death (SCD) in whom implantation of a cardioverter defibrillator (IC...
Autores principales: | Rohrer, U, Reischl, A, Manninger, M, Ebner, C, Moertl, D, Keller, H, Dirninger, A, Stix, G, Alber, H, Steinwender, C, Binder, R, Stuehlinger, M, Zirlik, A, Scherr, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206815/ http://dx.doi.org/10.1093/europace/euad122.348 |
Ejemplares similares
-
Subcutaneous implantable cardioverter-defibrillator generator removal: a multicenter analysis
por: Luker, J, et al.
Publicado: (2023) -
The phospholamban (PLN) p.Arg14del risk model; Longitudinal validation and reevaluation of predictors regarding sudden cardiac death (SCD)
por: Van Der Heide, M Y C, et al.
Publicado: (2023) -
Cardiac defibrillator implantation in patients with syncope and inducible ventricular arrhythmia: insights from the German DEVICE registry
por: Kahle, A K, et al.
Publicado: (2023) -
Utility of cardiac magnetic resonance in assessing arrhythmic risk in patients with non ischemic cardiomyopathy undergoing biventricular pacing
por: Sayed, M, et al.
Publicado: (2023) -
QRS complex and T wave planarity for the prediction of death and appropriate shocks in recipients of prophylactic implantable defibrillators
por: Novotny, T, et al.
Publicado: (2023)